Professional Documents
Culture Documents
Tweet
Day in Health
by Lisa Collier Cool
Recent Posts
Best And Worst Celebrity Health Advice A New Test to Predict Heart Attacks Can chilly weather really cause a cold? Amazing Facts About Laughter More Articles
Related Topics
Albinism Cancer
Hannah Kiefer thought she looked pretty with a tanuntil she was diagnosed with melanoma, the deadliest form of skin cancer, at age 21. I was addicted to tanning in high school and college, but I never thought I was at risk, because I have olive skin and dont get sunburns, says Kiefer, then a college junior. Kiefer also thought she was much too young to worry about skin cancer. Actually, rates of melanoma have soared by eight-fold among young women over the past 40 years, and by four-fold among young men, a 2012 Mayo Clinic study found. In fact, its now the leading form of cancer among young adults, ages 25 to 29, and the second most common cancer in teens, according to the American Academy of Dermatology (AAD), which has designated May 6th as Melanoma Monday, as part of an initiative to raise awareness of skin cancer risk. The AAD asks Americans to support its SPOT Orange initiative by sharing photos of themselves, their friends, family or pets wearing orange on Melanoma Monday. The goal is to encourage early detection of melanoma and other skin cancer through self-exams.
(such as basal cell carcinoma) are at increased risk for melanoma, breast cancer, and lung cancer, even after other risks, such as smoking, were taken into account. However, the good news is that skin cancer is highly preventable, because the #1 risk factor is exposure to UV light. A 2011 randomized study found that people who used sunscreen daily had only had half the rate of melanoma as those who applied it less often (or not at all). Head Lice Prevention
works for about 20 percent of patients, cautions Dr. Saenger. Vemurafenib. About 60 percent of melanomas have a mutated gene called BRAF that plays role in their growth, reports Dr. Saenger. Sold under the brand name Zelboraf, this FDA-approved pillthe first targeted therapy for melanomanearly doubled survival of patients with advanced melanoma in a 2012 study. Lambrolizumab. Classified as a breakthrough therapy by the FDA in April, according to its manufacturer, this still experimental drug has shown promising results in a small clinical trial. Its an antibody therapy that targets the programmed death receptor.
which patients will be treated with OncoVEX and Yervoy, to see if combination therapy boosts response rate.